drug
desvenlafaxine succinate ER
Marketedupdated 3mo agoby Intellipharmaceutics Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4indications
investigational
Major Depression
all catalysts(1)
Trials studying desvenlafaxine succinate ER
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 5, 2027
328 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Jul 5, 2027compositionUS 8269040328d
- Jul 5, 2027compositionUS 8269040328d
- Jul 5, 2027compositionUS 8269040328d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that